Renard P, Hillon P, Bedenne L, Fourot M, Milan C, Faivre J, Klepping C
Service d'Hépato-Gastro-Entérologie, Hôpital Général, Dijon.
Ann Gastroenterol Hepatol (Paris). 1991 Jan-Feb;27(1):7-12.
In this retrospective study, the prevalence of hepatitis B virus markers was studied in groups of heavy drinkers and primary hepatocellular carcinoma patients (202 patients), hospitalized for the first time in a medical department of gastroenterology in France. HBs Ag, anti-HBs and anti-HBc were respectively detected in 1.1, 25.8 and 20.9 p. cent of alcoholic patients without hepatocellular carcinoma. The overall prevalence of hepatitis B virus infection was 26.9 p. cent. The presence of hepatitis B virus markers did not depend on excess alcohol consumption, sex, age, alcoholic liver disease intensity, or previous gastrointestinal bleeding or hospitalization, but was related to racial group and residence in countries with a high prevalence of HBs Ag. HBs Ag, anti-HBs and anti-HBc were observed in 0, 36.4 and 36.4 p. cent of the alcoholic cirrhotic patients with hepatocellular carcinoma and the prevalence of hepatitis B virus markers was 45.5 p. cent. The findings reported in this study suggest that hepatitis B virus infection has no major role in determining the rate of progression of alcoholic liver disease and plays a far lesser causal role in hepatocellular carcinoma in France than in high incidence regions.
在这项回顾性研究中,对法国一家胃肠病医学科首次住院的重度饮酒者和原发性肝细胞癌患者(202例)群体进行了乙型肝炎病毒标志物患病率的研究。在无肝细胞癌的酒精性肝病患者中,HBs Ag、抗-HBs和抗-HBc的检出率分别为1.1%、25.8%和20.9%。乙型肝炎病毒感染的总体患病率为26.9%。乙型肝炎病毒标志物的存在并不取决于过量饮酒、性别、年龄、酒精性肝病的严重程度,或既往胃肠道出血或住院情况,而是与种族群体以及居住在HBs Ag高流行率的国家有关。在患有肝细胞癌的酒精性肝硬化患者中,HBs Ag、抗-HBs和抗-HBc的检出率分别为0、36.4%和36.4%,乙型肝炎病毒标志物的患病率为45.5%。本研究报告的结果表明,在法国,乙型肝炎病毒感染在决定酒精性肝病的进展速度方面没有主要作用,在肝细胞癌中的因果作用远小于高发病率地区。